1. Home
  2. OGEN vs ASTI Comparison

OGEN vs ASTI Comparison

Compare OGEN & ASTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OGEN
  • ASTI
  • Stock Information
  • Founded
  • OGEN 1996
  • ASTI 2005
  • Country
  • OGEN United States
  • ASTI United States
  • Employees
  • OGEN N/A
  • ASTI N/A
  • Industry
  • OGEN Biotechnology: Pharmaceutical Preparations
  • ASTI Semiconductors
  • Sector
  • OGEN Health Care
  • ASTI Technology
  • Exchange
  • OGEN Nasdaq
  • ASTI Nasdaq
  • Market Cap
  • OGEN 2.5M
  • ASTI 2.9M
  • IPO Year
  • OGEN N/A
  • ASTI N/A
  • Fundamental
  • Price
  • OGEN $1.39
  • ASTI $2.08
  • Analyst Decision
  • OGEN
  • ASTI
  • Analyst Count
  • OGEN 0
  • ASTI 0
  • Target Price
  • OGEN N/A
  • ASTI N/A
  • AVG Volume (30 Days)
  • OGEN 1.2M
  • ASTI 6.7M
  • Earning Date
  • OGEN 08-08-2025
  • ASTI 08-05-2025
  • Dividend Yield
  • OGEN N/A
  • ASTI N/A
  • EPS Growth
  • OGEN N/A
  • ASTI N/A
  • EPS
  • OGEN N/A
  • ASTI N/A
  • Revenue
  • OGEN N/A
  • ASTI $51,917.00
  • Revenue This Year
  • OGEN N/A
  • ASTI N/A
  • Revenue Next Year
  • OGEN N/A
  • ASTI N/A
  • P/E Ratio
  • OGEN N/A
  • ASTI N/A
  • Revenue Growth
  • OGEN N/A
  • ASTI N/A
  • 52 Week Low
  • OGEN $1.34
  • ASTI $1.10
  • 52 Week High
  • OGEN $75.60
  • ASTI $11.10
  • Technical
  • Relative Strength Index (RSI)
  • OGEN 26.99
  • ASTI 51.97
  • Support Level
  • OGEN $1.40
  • ASTI $2.10
  • Resistance Level
  • OGEN $1.58
  • ASTI $2.64
  • Average True Range (ATR)
  • OGEN 0.28
  • ASTI 0.49
  • MACD
  • OGEN -0.13
  • ASTI -0.00
  • Stochastic Oscillator
  • OGEN 2.44
  • ASTI 37.32

About OGEN Oragenics Inc.

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.

About ASTI Ascent Solar Technologies Inc.

Ascent Solar Technologies Inc is engaged in the manufacturing, and selling of photovoltaic products (PV) solar modules that are flexible, durable, and possess attractive power-to-weight and power-to-area performance. The company is integrating its PV products into scalable and high-value markets such as agrivoltaics, aerospace, satellites, near-earth orbiting vehicles, and fixed-wing unmanned aerial vehicles (UAV). Ascent is also working to expand its portable solar chargers, such as the XD-12. The company markets and sells its products through OEMs, system integrators, distributors, retailers, and e-commerce companies.

Share on Social Networks: